Wave Life Sciences Inc WVE

$3.18 -0.17 (-5.07%)

Valuation

Market cap
664,658,000
Revenue TTM
$42,730,000
Net income TTM
$-204,380,000
PE ratio
0.00
Forward PE
—
Profit margin
-478.31%
Debt to equity
0.00

Trading

Volume
2,654,010
Avg volume
3,240,548
Day's range
$3.12 – $3.33
Shares out
197,228,000
Stochastic %K
69%
Beta
-1.43
Analysts
Strong Sell
Price target
$18.58

Price

Company profile

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 anti...

Show more

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 949 2900
Website
https://wavelifesciences.com
Address
733 Concord Avenue, Cambridge, United States

Latest news

Stocktwits

CargoShorts4Life Oct 23, 5:07 PM
$WVE bought more April calls.
0 replies
Patrick2343 Oct 23, 4:23 PM
$WVE boy do the shorts seem to love this stock
0 replies
ACH50 Oct 23, 12:07 PM
$WVE chart/indicators look primed to inch upwards.
0 replies
CargoShorts4Life Oct 22, 4:02 PM
$WVE extremely
0 replies
johnnygogogo Oct 22, 2:24 PM
$WVE this valuation makes zero fucking sense except someone is cheating to accumulate.
0 replies
Bioboarder Oct 22, 12:41 PM
$WVE Are you seeing the data from KRRO regarding AATD today? What’s your take on it?
1 replies
hichemben Oct 22, 8:10 AM
$WVE I saw this update 2 days ago on their LinkedIn page🙌🏼 Bringing on Gemma Mandell as VP, Head of Regulatory directly reinforces Wave’s shift from an early discovery biotech into a commercial registrational company🔥 Let's gooo🚀🚀🚀 Why now? Gemma spent 6.5 years at Blueprint Medicines as VP of Global Regulatory Sciences: - At Blueprint, regulatory leadership navigated and executed the FDA and EMA approvals for AYVAKIT® - Her operational background is built on accelerated approval pathways and negotiate protocol with FDA
1 replies
uranumo Oct 20, 7:18 PM
$WVE in case the Dose report is positive, how do you guys see the price rise? What could the ceiling be ?
2 replies